{{Rsnum
|rsid=1432295
|Chromosome=2
|position=60839531
|Orientation=plus
|GMAF=0.2282
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.0 | 49.6 | 19.5
| HCB | 96.3 | 3.7 | 0.0
| JPT | 93.8 | 6.2 | 0.0
| YRI | 83.7 | 15.6 | 0.7
| ASW | 68.4 | 28.1 | 3.5
| CHB | 96.3 | 3.7 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 79.2 | 18.8 | 2.0
| LWK | 82.7 | 15.5 | 1.8
| MEX | 60.3 | 31.0 | 8.6
| MKK | 72.1 | 25.3 | 2.6
| TSI | 40.6 | 42.6 | 16.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21037568
|Title=A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
}}

[[Hodgkin lymphoma]]

{{PMID Auto GWAS
  |PMID=24149102
  |Trait=Hodgkin's lymphoma
  |Title=Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
  |RiskAllele=G
  |Pval=1E-6
  |OR=1.24
  |ORtxt=[NR]
  }}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}